PCSK9 inhibitors – Recognising innovation in cholesterol treatment to address a UK health burden
Health Service Journal,
Increasing the use of PCSK9 inhibitors in patients at high-risk of cardiovascular disease (CVD) supports national efforts to…
Increasing the use of PCSK9 inhibitors in patients at high-risk of cardiovascular disease (CVD) supports national efforts to…
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a…